Security key
09060C507
BIO KEY INTERNATIONAL INC - Common Stock, $0.0001 par value per share (BKYI)
CUSIP: 09060C507
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 6,804
- Total 13F value
- $14,277
- Share change
- -66,089
- SEC-reported price per share
- $2.10
- Number of holders
- 8
- Value change
- -$197,593
- Number of buys
- 4
- Number of sells
- 2
- Shares outstanding
- 7,208,477
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
8
Top holders
8
BKYI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
BIO KEY INTERNATIONAL INC SEC filings
BIO KEY INTERNATIONAL INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09060C507
Recent filing periods:
Ownership snapshot
Top reported holders of BKYI - BIO KEY INTERNATIONAL INC - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/10
Latest evidence
31 Dec 2023
13F
3/4/5
Highest disclosed value: $196,002
10 rows are not safely comparable across share classes.
Showing 1-6 of 10 holder rows.
Quick read
ARMISTICE CAPITAL, LLC has the largest disclosed position value at $196K.
0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value
Top 5
ARMISTICE CAPITAL, LLC
$196K
Pieter C. Knook
$71.8K
Thomas Bush III
$66.9K
Thomas Gilley
$41.5K
Tower Research Capital LLC (TRC)
$18.5K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
denominator unverified
|
$196,002
65,334 shares
|
— | 31 Dec 2023 |
| Pieter C. Knook |
3/4/5
Director
|
—
denominator unverified
|
$71,772
28,146 shares
|
— | 11 May 2023 |
| Thomas Bush III |
3/4/5
Director
|
—
denominator unverified
|
$66,920
26,243 shares
|
— | 11 May 2023 |
| Thomas Gilley |
3/4/5
Director
|
—
denominator unverified
|
$41,540
16,290 shares
|
— | 10 Nov 2022 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
—
denominator unverified
|
$18,525
6,175 shares
|
— | 31 Dec 2023 |
| OSAIC HOLDINGS, INC. |
13F
Company
|
—
denominator unverified
|
$3,000
1,000 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
6,804
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2026 Across Filers
Q1 2026 holders
9
Q1 2024 holders
8
Holder diff
-1
| Investor | Q1 2026 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend